Drug Approval | June 17, 2024
Alembic announces USFDA final approval for Icatibant injection
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Jubilant's Radiopharma Business to expand positron emission tomography radiopharmacy network
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
This strategic decision will unlock significant value for our scientific and industrial products business
Subscribe To Our Newsletter & Stay Updated
